Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesPharmacy & Specialty DrugsIndependent Health step therapy Coverage & Prior A…
    Ask Trek AI about this page
    CurrentIndependent HealthPolicy N/A

    Step therapy criteria for Child Health Plus formulary medications

    Customize your policy alerts

    Sign up for all Independent Health policy alerts

    Know when Independent Health releases new policies or updates existing guidance.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Defines step therapy protocols that apply to Independent Health's 2025 Child Health Plus formulary; describes which medications require prior trial of specified agents or documentation in pharmacy history before coverage or prior authorization is applied. Affects providers prescribing and pharmacies filling medications for Child Health Plus members.

    Policy Summary
    PayerIndependent Health
    PolicyStep therapy criteria for Child Health Plus formulary medications
    Policy CodePolicy N/A
    Change TypeNo material change
    Effective DateJan 1, 2025
    Last ReviewJan 1, 2025
    Next Review DateN/A
    Key ActionVerify required prior pharmacy fills or diagnosis in the member's Independent Health prescription history within the product-specific lookback window; obtain prior authorization if criteria are not met.
    SourceLink

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    20+medication product groups listed
    Child Health Plusformulary referenced
    90–365dlookback periods
    6+products with step/PA rules
    90dcommon lookback
    120dUbrelvy triptan lookback

    Coverage Criteria — Product-specific Step Rules

    Airsupra

    Covered when ALL of the following are met:

    Airsupra criteria: Pharmacy history documents an inhaled corticosteroid or its combination (e.g., budesonide inhalation suspension or fluticasone-salmeterol) filled within the previous 120 days.120 days

    If not documented, prior authorization is required.

    GLP-1 antidiabetic agents

    Covered when ONE of the following is documented in the Independent Health pharmacy history:

    GLP-1 criteria: Documentation of type 2 diabetes OR trial of any oral antidiabetic medication (excluding metformin) within the past 130 days.130 days

    Applies to listed GLP-1 products (e.g., Mounjaro, Ozempic, Rybelsus, Trulicity). If not documented, prior authorization is required.

    Entacapone

    Covered when ALL of the following are met:

    Entacapone criteria: Pharmacy history documents concurrent use of carbidopa/levodopa.concurrent use

    If not documented, prior authorization is required.

    Desonide 0.05%

    Covered when ALL of the following are met:

    Desonide criteria: Pharmacy history documents a fill for alclometasone within the previous 90 days.90 days

    If not documented, prior authorization is required.

    Aprepitant

    Covered when ALL of the following are met:

    Aprepitant criteria: Pharmacy history documents at least a five-day supply of dexamethasone filled within the previous 90 days.90 days

    If not documented, prior authorization is required.

    Eucrisa

    Covered when ANY of the following are met:

    Eucrisa criteria: Pharmacy history documents prior use of a topical corticosteroid OR a topical calcineurin inhibitor (e.g., pimecrolimus or tacrolimus) within the previous 365 days.365 days

    If not documented, prior authorization is required.

    Granisetron

    Covered when ALL of the following are met:

    Granisetron criteria: Pharmacy history documents ondansetron filled within the previous 180 days.180 days

    If not documented, prior authorization is required.

    Long-acting and abuse-deterrent opioids

    Covered when ALL of the following are met:

    Opioid products criteria: Pharmacy history documents that narcotic medications were filled within the previous 120 days.120 days

    Applies to listed long-acting and abuse‑deterrent opioid products; if not documented, prior authorization is required.

    Aliskiren

    Covered when ALL of the following are met:

    Aliskiren criteria: Pharmacy history documents fills for an ACE inhibitor AND an ARB within the previous 90 days.90 days

    If not documented, prior authorization is required.

    Serevent Diskus

    Covered when ONE of the following is documented in the pharmacy history:

    Serevent criteria: Pharmacy history documents concurrent use of an inhaled corticosteroid OR tiotropium (Spiriva).concurrent use

    If not documented, prior authorization is required.

    Serevent Diskus (alternate index)

    Online routing occurs when ONE of the following is present in the pharmacy profile:

    Serevent online routing: Claim routes online if pharmacy history documents concurrent use of an inhaled corticosteroid or Spiriva.concurrent use documented

    If not documented, prior authorization is required.

    Tramadol ER

    Initial coverage routing — covered when ALL of the following are met:

    Tramadol ER initial: Pharmacy history documents immediate‑release tramadol filled within the previous 90 days.90 days

    If not documented, prior authorization is required and claim will not route online.

    Ubrelvy

    Covered when ONE of the following is documented in the pharmacy history:

    Ubrelvy online routing: Pharmacy history documents a generic triptan product (e.g., sumatriptan, naratriptan, rizatriptan) filled within the previous 120 days.120 days

    If not documented, prior authorization is required.

    Febuxostat

    Covered when ONE of the following is documented in the pharmacy history:

    Febuxostat online routing: Pharmacy history documents that allopurinol was filled within the previous 90 days.90 days

    If not documented, prior authorization is required.

    This excerpt contains the Step Therapy Criteria applicable to Independent Health's 2025 Child Health Plus formulary. No explicit clinical exclusions are listed in this part of the document; the rules shown rely on documented pharmacy history or diagnosis to route claims or trigger prior authorization rather than stating specific patient-level exclusions.

    For the products shown in this excerpt, the policy sets coverage routing based on the member's pharmacy history (for example, documented concurrent controller therapy for inhalers). No explicit clinical exclusions for these products are provided within this section — coverage decisions are determined by the presence or absence of required prior fills rather than named clinical contraindications.

    Within this portion of the policy there are no statements declaring items 'not medically necessary'. Instead, the document describes step therapy checks and prior authorization triggers tied to pharmacy history and predefined lookback windows; absence of required history prompts prior authorization rather than an explicit non‑coverage declaration.

    Coding and Lookback Windows

    GLP-1 and related antidiabetic productsNDC | description
    MOUNJARO SOLUTION AUTO-INJECTOR 10 MG/0.5ML SUBCUTANEOUSlisted product
    OZEMPIC (2 MG/DOSE) SOLUTION PEN-INJECTOR 8 MG/3ML SUBCUTANEOUSlisted product
    RYBELSUS TABLET 14 MG ORALlisted product
    TRULICITY SOLUTION AUTO-INJECTOR 0.75 MG/0.5ML SUBCUTANEOUSlisted product
    Long-acting and abuse-deterrent opioid productsNDC | description
    FENTANYL PATCH 72 HOUR 100 MCG/HR TRANSDERMALlisted product
    HYDROCODONE BITARTRATE ER TABLET 24 HOUR 100 MG ORALlisted product
    MORPHINE SULFATE ER CAPSULE 24 HOUR 100 MG ORALlisted product
    NUCYNTA ER TABLET EXTENDED RELEASE 12 HOUR 100 MG ORALlisted product
    EntacaponeNDC | description
    entacapone tablet 200 mg orallisted product
    Topical PDE4 inhibitor (Eucrisa)NDC | description
    EUCRISA OINTMENT 2 % EXTERNALlisted product
    Antiemetic - granisetronNDC | description
    granisetron hcl tablet 1 mg orallisted product
    AliskirenNDC | description
    aliskiren fumarate tablet 150 mg orallisted product
    aliskiren fumarate tablet 300 mg orallisted product
    LABA - Serevent DiskusNDC | description
    SEREVENT DISKUS AEROSOL POWDER BREATH ACTIVATED 50 MCG/ACT INHALATIONlisted product
    Lookback periods for prior therapy — examples
    Examples of lookback periods90 days; 120 days; 130 days; 180 days; 365 days
    Used for topical/short‑course therapies90 days (e.g., desonide, aprepitant dexamethasone supply)
    Used for inhaled controller / concurrent therapy checks120 days (e.g., Airsupra inhaled corticosteroid requirement; Serevent concurrent controller)
    Used for oral antidiabetic/GLP‑1 evaluation130 days (GLP‑1 agents: type 2 diabetes or oral antidiabetic trial excluding metformin)
    Used for antiemetic/ondansetron history180 days (granisetron requires ondansetron fill within prior 180 days)

    Provider Actions — Prior Authorization Triggers & Documentation

    Prior Authorization

    Prior authorization required when history criteria not met

    Many medications require prior authorization when the member’s Independent Health pharmacy history does not document the product-specific prior therapy or diagnosis within the lookback window; absence of the required history will trigger a PA requirement and may result in denial without an approved authorization.

    • Lookback windows vary by product (examples: 90, 120, 130, 180, 365 days).
    • Specific products and their required prior therapy are described in product-level rules below.
    Prior Authorization

    Serevent prior authorization

    If the pharmacy profile does not document concurrent use of an inhaled corticosteroid or Spiriva (tiotropium), prior authorization is required for Serevent Diskus.

    • Claim routes online only when pharmacy history documents concurrent inhaled corticosteroid or Spiriva.

    Background and Policy Purpose

    Step therapy is used to ensure that members try clinically appropriate, typically less expensive or preferred therapies before receiving other formulary medications. The protocol in this document enforces step requirements by checking the member's Independent Health pharmacy history for prior fills or documented diagnoses within specified lookback windows; if the required prior therapy is not documented, a prior authorization is required to process the claim.

    Definitions

    Step therapy — definition (compact)
    DefinitionStep therapy requires that a member try specified initial (usually preferred or lower‑cost) medication(s) or document prior therapy in pharmacy history before coverage of another formulary medication is allowed
    Formulary indicatorMedications that require step therapy are marked 'ST' in the Notes column of the Child Health Plus formulary
    Enforcement methodStep requirements are enforced by checking Independent Health pharmacy history for the product‑specific prior fills or diagnoses within defined lookback windows; absence of required history triggers prior authorization

    Initial Therapy Criteria

    GLP-1 initial therapy

    Initial therapy — covered when ONE of the following is documented in the Independent Health pharmacy history:

    GLP-1 initial: Documentation of type 2 diabetes OR prior use of an oral antidiabetic medication (excluding metformin) within the previous 130 days.130 days

    Applies to listed GLP-1 products; absence requires prior authorization.

    Tramadol ER initial therapy

    Initial therapy — covered when ALL of the following are met:

    Tramadol ER initial: Immediate‑release tramadol fill within the previous 90 days documented in pharmacy history.90 days

    If not documented, prior authorization is required.

    Step Therapy Operational Table

    Step therapy enforcement
    Step therapy is enforced by checking the member's Independent Health pharmacy history for required prior fills of specified medications within each product-specific lookback window; absence of the required history triggers prior authorization.
    ProductRequired pharmacy documentationAction if not documented
    {"text":"Serevent Diskus (salmeterol)","status":""}|{"text":"Pharmacy profile documents concurrent use of an inhaled corticosteroid OR tiotropium (Spiriva)","status":""}|{"text":"Prior authorization required if concurrent controller not documented; claim will not route online","status":""}
    ProductRequired pharmacy documentationLookback window / Action if not documented
    {"text":"Tramadol extended‑release preparations","status":""}|{"text":"Pharmacy history documents an immediate‑release tramadol fill","status":""}|{"text":"90 days lookback — prior authorization required if not documented","status":""}
    ProductRequired pharmacy documentationLookback window / Action if not documented
    {"text":"Ubrelvy (ubrogepant)","status":""}|{"text":"Pharmacy history documents a generic triptan (e.g., sumatriptan, naratriptan, rizatriptan)","status":""}|{"text":"120 days lookback — prior authorization required if not documented","status":""}
    ProductRequired pharmacy documentationLookback window / Action if not documented
    {"text":"Febuxostat (Uloric)","status":""}|{"text":"Pharmacy history documents an allopurinol fill","status":""}|{"text":"90 days lookback — prior authorization required if not documented","status":""}
    Policy Summary
    PayerIndependent Health
    PolicyStep therapy criteria for Child Health Plus formulary medications
    Policy CodePolicy N/A
    Change TypeNo material change
    Effective DateJan 1, 2025
    Last ReviewJan 1, 2025
    Next Review DateN/A
    Key ActionVerify required prior pharmacy fills or diagnosis in the member's Independent Health prescription history within the product-specific lookback window; obtain prior authorization if criteria are not met.
    SourceLink
    On This Page
    Coverage Criteria — Product-specific Step RulesCoding and Lookback WindowsProvider Actions — Prior Authorization Triggers & DocumentationBackground and Policy PurposeDefinitionsInitial Therapy CriteriaStep Therapy Operational Table
    Used for prior topical calcineurin/corticosteroid use365 days (Eucrisa requires topical steroid or calcineurin inhibitor within prior 365 days)
    Prior fill lookback windows — common examples
    90‑day prior fill windowImmediate‑release tramadol and allopurinol: documented fill within previous 90 days allows online processing
    120‑day prior fill windowGeneric triptan products (for Ubrelvy): documented fill within previous 120 days allows online processing
    Product‑specific applicationThese lookback windows are applied per product to determine online routing vs. prior authorization (examples shown)
    Prior Authorization

    Tramadol ER prior authorization

    Prior authorization is required for extended‑release tramadol when the pharmacy profile does not document a fill of immediate‑release tramadol within the previous 90 days.

    • Online routing allowed only if an immediate‑release tramadol fill is documented within the 90‑day lookback.
    Prior Authorization

    Ubrelvy prior authorization

    Prior authorization is required for Ubrelvy (ubrogepant) when the pharmacy profile does not document a generic triptan fill within the previous 120 days.

    • Examples of acceptable generics include sumatriptan, naratriptan, rizatriptan as documented in pharmacy history.
    Prior Authorization

    Febuxostat prior authorization

    Prior authorization is required for febuxostat (Uloric) when the pharmacy profile does not document an allopurinol fill within the previous 90 days.

    • Online routing permitted only if allopurinol fill is present in the 90‑day lookback window.
    Step Therapy

    Formulary step therapy designation — ST designation note

    Medications listed with an 'ST' designation on the Child Health Plus formulary are subject to the step therapy protocols in this document; the initial step is verification of the product‑specific prior therapy or diagnosis in the member's pharmacy history.

    • If the required prior therapy is not documented, prior authorization is required per the product rule.
    Step Therapy

    Serevent step rule

    Serevent Diskus requires documented concurrent use of an inhaled corticosteroid or tiotropium (Spiriva) on the pharmacy profile to satisfy the step and allow online processing; absence requires prior authorization.

    • Concurrent controller documentation is the step required for online routing.
    Step Therapy

    Tramadol ER step rule

    Extended‑release tramadol products require a documented immediate‑release tramadol fill within the previous 90 days as the step to allow online processing; otherwise prior authorization is required.

    • 90‑day lookback for immediate‑release tramadol is enforced.
    Step Therapy

    Ubrelvy step rule

    Ubrelvy (ubrogepant) requires documentation of a generic triptan fill within the previous 120 days as the step to permit online routing; if not documented, prior authorization is required.

    • Acceptable evidence is a pharmacy fill for a generic triptan within 120 days.
    Step Therapy

    Febuxostat step rule

    Febuxostat (Uloric) requires documentation that allopurinol was filled within the previous 90 days as the step to allow online processing; absence of that fill triggers prior authorization.

    • 90‑day allopurinol lookback applies to both 40 mg and 80 mg febuxostat products.
    Documentation Required

    Required pharmacy history documentation — general

    Pharmacy profile/prescription history must document the product‑specific prior fills or diagnoses within the defined lookback windows (examples: 90, 120, 130, 180, 365 days) to satisfy step requirements; absence will require prior authorization.

    • Lookback window examples: GLP‑1 agents 130 days; Ubrelvy 120 days; tramadol ER and febuxostat 90 days; granisetron 180 days; Eucrisa 365 days.
    Documentation Required

    Serevent documentation — concurrent inhaled corticosteroid or tiotropium

    For Serevent Diskus, document concurrent use of an inhaled corticosteroid or tiotropium (Spiriva) in the pharmacy/prescription history to meet the requirement and allow online processing.

    • If not documented, a prior authorization will be required.
    Documentation Required

    Tramadol ER documentation — immediate‑release tramadol within 90 days

    For extended‑release tramadol prescriptions, include prescription history showing an immediate‑release tramadol fill within the previous 90 days to meet the step requirement and avoid prior authorization.

    • 90‑day lookback must show immediate‑release tramadol fill.
    Documentation Required

    Ubrelvy documentation — generic triptan within 120 days

    For Ubrelvy, provide prescription history documenting a generic triptan fill (e.g., sumatriptan, naratriptan, rizatriptan) within the previous 120 days to meet the step requirement and allow online processing.

    • 120‑day lookback for a generic triptan is required.
    Documentation Required

    Febuxostat documentation — allopurinol within 90 days

    For febuxostat, ensure the pharmacy history documents an allopurinol fill within the previous 90 days (for either 40 mg or 80 mg strengths) to meet the step requirement and avoid prior authorization.

    • 90‑day allopurinol fill must be present in pharmacy history.
    Documentation Required

    Airsupra: inhaled corticosteroid history required

    Airsupra prescriptions require pharmacy history documentation that an inhaled corticosteroid or its combination was filled within the previous 120 days; absence of that documentation will require prior authorization.

    • 120‑day lookback for inhaled corticosteroid or combination (examples: budesonide suspension, fluticasone‑salmeterol).
    Denial Risk

    GLP-1 agents: prior oral antidiabetic or diagnosis required

    For GLP‑1 antidiabetic agents, pharmacy history must document type 2 diabetes OR a trial of any oral antidiabetic (excluding metformin) within the previous 130 days; if neither is documented, prior authorization is required.

    • 130‑day lookback applies to GLP‑1 products listed on the formulary.
    Documentation Required

    Entacapone: concurrent carbidopa/levodopa required

    Entacapone requires pharmacy history documenting concurrent use of carbidopa/levodopa; absence of concurrent carbidopa/levodopa will require prior authorization.

    • Concurrent carbidopa/levodopa must appear in the member’s prescription history.
    Documentation Required

    Desonide: prior topical steroid required

    Desonide 0.05% requires prior pharmacy documentation that alclometasone was filled within the previous 90 days; without that prior topical steroid fill, prior authorization will be required.

    • 90‑day lookback for alclometasone is enforced.
    Documentation Required

    Aprepitant: dexamethasone history required

    Aprepitant products require pharmacy history documentation of at least a five‑day supply of dexamethasone filled within the previous 90 days; absence will require prior authorization.

    • Document a five‑day dexamethasone supply within 90 days in the prescription history.
    Documentation Required

    Eucrisa: prior topical therapy required

    Eucrisa ointment requires documented prior use of a topical corticosteroid or a topical calcineurin inhibitor (e.g., pimecrolimus or tacrolimus) within the previous 365 days; if not documented, prior authorization is required.

    • 365‑day lookback for prior topical corticosteroid or calcineurin inhibitor.
    Documentation Required

    Granisetron: ondansetron history required

    Granisetron requires pharmacy history documenting that ondansetron was filled within the previous 180 days; absence of that documentation will require prior authorization.

    • 180‑day lookback for ondansetron is enforced.
    Documentation Required

    Opioids: recent narcotic use required

    A range of long‑acting and abuse‑deterrent opioid products require documentation that narcotic medications were filled within the previous 120 days; lack of a recent narcotic fill will require prior authorization.

    • 120‑day lookback for prior narcotic medication fills applies to multiple listed opioid products.
    Documentation Required

    Aliskiren: ACE inhibitor and ARB history required

    Aliskiren tablets require pharmacy history documenting fills for an ACE inhibitor and an ARB within the previous 90 days; absence of both will require prior authorization.

    • 90‑day lookback for both ACE inhibitor and ARB fills is required.
    Denial Risk

    Serevent Diskus: concurrent controller required

    Serevent Diskus requires documentation of concurrent use of an inhaled corticosteroid or tiotropium (Spiriva) in the pharmacy history; if the profile does not document this concurrent controller therapy, the claim may be denied without prior authorization.

    • Concurrent inhaled corticosteroid or Spiriva must be present in the pharmacy profile to avoid denial.
    Denial Risk

    Serevent denial trigger

    If the pharmacy profile does not document concurrent inhaled corticosteroid or Spiriva use for Serevent Diskus, prior authorization is required and the claim may be denied without it.

    • Lack of documented controller therapy is a denial trigger for Serevent Diskus.
    Denial Risk

    Tramadol ER denial trigger

    If the pharmacy profile does not document an immediate‑release tramadol fill within the previous 90 days for extended‑release tramadol products, prior authorization is required and the claim may be denied without it.

    • Absence of the 90‑day immediate‑release tramadol fill is a denial trigger for tramadol ER.
    Denial Risk

    Ubrelvy denial trigger

    If the pharmacy profile does not document a generic triptan fill within the previous 120 days for Ubrelvy, prior authorization is required and the claim may be denied without it.

    • Absence of a 120‑day triptan fill is a denial trigger for Ubrelvy.
    Denial Risk

    Febuxostat denial trigger

    If the pharmacy profile does not document an allopurinol fill within the previous 90 days for febuxostat (Uloric), prior authorization is required and the claim may be denied without it.

    • Absence of a 90‑day allopurinol fill is a denial trigger for febuxostat.